Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

198 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patient's compliance with allergen immunotherapy.
Incorvaia C, Mauro M, Ridolo E, Puccinelli P, Liuzzo M, Scurati S, Frati F. Incorvaia C, et al. Among authors: ridolo e. Patient Prefer Adherence. 2008 Feb 2;2:247-51. doi: 10.2147/ppa.s3806. Patient Prefer Adherence. 2008. PMID: 19920970 Free PMC article.
Systematic reviews and heterogeneity.
Incorvaia C, Vighi G, Ridolo E. Incorvaia C, et al. Among authors: ridolo e. Ann Allergy Asthma Immunol. 2013 Oct;111(4):306. doi: 10.1016/j.anai.2013.07.007. Epub 2013 Aug 20. Ann Allergy Asthma Immunol. 2013. PMID: 24054374 No abstract available.
Omalizumab, an anti-immunoglobulin E antibody: state of the art.
Incorvaia C, Mauro M, Russello M, Formigoni C, Riario-Sforza GG, Ridolo E. Incorvaia C, et al. Among authors: ridolo e. Drug Des Devel Ther. 2014 Feb 7;8:197-207. doi: 10.2147/DDDT.S49409. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 24532966 Free PMC article.
Emerging drugs for allergic conjunctivitis.
Ridolo E, Montagni M, Caminati M, Senna G, Incorvaia C, Canonica GW. Ridolo E, et al. Expert Opin Emerg Drugs. 2014 Jun;19(2):291-302. doi: 10.1517/14728214.2014.902443. Epub 2014 Mar 25. Expert Opin Emerg Drugs. 2014. PMID: 24661261 Review.
198 results